Clinical Trial Update: Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial called REACT is evaluating a treatment for adults with type 2 diabetes mellitus and chronic kidney disease, and the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• REACT (Renal Autologous Cell Therapy)

Snippet

Sponsor: Prokidney | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases | Phase 3 | Status: RECRUITING